These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 3785417)
1. Clinical pharmacology. New hopes for the treatment of coronary heart disease. Thompson G Nature; 1986 Dec 4-10; 324(6096):412. PubMed ID: 3785417 [No Abstract] [Full Text] [Related]
2. Cholesterol-lowering and vascular reactivity in relation to coronary heart disease. de Divitiis M; Rubba P Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):133-42. PubMed ID: 10464786 [TBL] [Abstract][Full Text] [Related]
3. Cholesterol hypothesis vindicated by simvastatin study. Why did it take so long? Beamish RE; Dhalla NS Can J Cardiol; 1995 Mar; 11(3):191-2. PubMed ID: 7889435 [No Abstract] [Full Text] [Related]
4. A need to redefine the consensus on the use of statins in coronary heart disease prevention. Fruchart JC Eur Heart J; 2000 Oct; 21(19):1572-3. PubMed ID: 10988008 [No Abstract] [Full Text] [Related]
5. Editorial introduction. Human lipoprotein metabolism and therapeutic options for coronary heart disease (CHD) reduction. Schaefer EJ Curr Opin Lipidol; 2013 Jun; 24(3):191. PubMed ID: 23652566 [No Abstract] [Full Text] [Related]
6. In patients with heart disease, is the benefit of lipid-lowering therapy with statins similar in older patients to that in younger patients? Adelman A J Fam Pract; 2001 Nov; 50(11):924. PubMed ID: 11711002 [No Abstract] [Full Text] [Related]
7. Hypercholesterolemia in children. Shamir R; Lerner A; Fisher EA Isr Med Assoc J; 2000 Oct; 2(10):767-71. PubMed ID: 11344730 [No Abstract] [Full Text] [Related]
8. [Prevention and treatment of coronary heart disease: lowering LDL, increasing HDL or monitoring both?]. Windler E Internist (Berl); 1996 Jun; 37(6):643-6. PubMed ID: 8768000 [No Abstract] [Full Text] [Related]
9. Hypercholesterolemia. Is lipid-lowering worthwhile for older patients? Deedwania PC Geriatrics; 2000 May; 55(5):22-8. PubMed ID: 10826262 [TBL] [Abstract][Full Text] [Related]
10. [Statins in secondary prevention of coronary heart disease]. Sandhofer F Wien Med Wochenschr; 1999; 149(5-6):125-8. PubMed ID: 10408003 [TBL] [Abstract][Full Text] [Related]
11. [For my coronary heart disease patients I strive for a 70 mg/dl LDL level (interview by Dr. med. Dirk Einecke)]. Bode C MMW Fortschr Med; 2005 Jun; 147(23):49. PubMed ID: 15981909 [No Abstract] [Full Text] [Related]
12. Aggressive medical therapy for the prevention and treatment of coronary artery disease. Malloy MJ; Kane JP Dis Mon; 1998 Jan; 44(1):1-40. PubMed ID: 9457050 [No Abstract] [Full Text] [Related]
13. What do the statin trials tell us? Waters DD Am J Manag Care; 2001 May; 7(5 Suppl):S138-43. PubMed ID: 11383375 [TBL] [Abstract][Full Text] [Related]
14. Evidence mandating earlier and more aggressive treatment of hypercholesterolemia. Steinberg D; Glass CK; Witztum JL Circulation; 2008 Aug; 118(6):672-7. PubMed ID: 18678783 [No Abstract] [Full Text] [Related]
15. [The role of cholesterol-lowering drugs in prevention of coronary heart disease]. Skałuba Z; Undas R Przegl Lek; 1998; 55(7-8):382-7. PubMed ID: 10021881 [TBL] [Abstract][Full Text] [Related]
16. [Cholesterol: how and when to treat it?]. Masana Marín L Med Clin (Barc); 1985 Oct; 85(10):423-5. PubMed ID: 4079497 [No Abstract] [Full Text] [Related]
17. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS). Lim PO; Yee KM Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109 [No Abstract] [Full Text] [Related]